COVID-19 News & Media

News and Information on COVID-19

Latest COVID-19 News

Feb 24 2021

Walgreens to Make Pixel by Labcorp™ COVID-19 PCR Test Home Collection Kit Available Over-The-Counter at Stores Nationwide

Kit to be available for purchase at Walgreens without a prescription and will allow for greater access to testing, helping reduce the spread of COVID-19 and improve the health of communities

DEERFIELD, Ill. & BURLINGTON, N.C., February 24, 2021 - As part of Walgreens ongoing efforts to increase access to COVID-19 testing in communities across the U.S., the company announced today it has entered into an agreement with Labcorp™ to sell Pixel by Labcorp COVID-19 PCR Test Home Collection Kits over-the-counter in up to 6,000 Walgreens stores nationwide beginning in spring of this year. Walgreens is making significant strides to increase on-site testing capacity at more than 5,000 Walgreens pharmacy locations by April 1, with more than half of sites located in socially vulnerable areas.

Read more »

Tracking COVID-19 Variants

We have been regularly tracking variants of the virus throughout the pandemic. The sensitivity of our PCR test is not impacted by these variants.

Labcorp PCR Test Performance Confirmed

Checkmark
Variant B.1.1.7 (Common name: U.K. Variant)
Checkmark
Variant B.1.351 (Common name: South African Variant)
Checkmark
Variant P.1 (Common name: Brazil Variant)
Checkmark
Variant B.1.526 (Common name: New York Variant)

Labcorp has been working with the Centers for Disease Control and Prevention (CDC) to provide sequencing of samples of SARS-CoV-2, the virus that causes COVID-19.

For more information visit US COVID-19 Cases Caused by Variants on the CDC website. 

Previous News Releases and Media Statements

Feb 19 2021

Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19

Labcorp Using PacBio’s HiFi Sequencing to Detect SARS-CoV-2 Variants in the U.S.

Read more »
Feb 17 2021

Labcorp Adds High Sensitivity Antigen Test to Screen for Active COVID-19 Infection

Antigen Test Is the Latest Offering by Labcorp to Fight COVID-19 at Every Stage, from Diagnostic Testing to Clinical Trials and Vaccination Services

Read more »
Jan 8 2021

Media Statement: Tracking Mutations of the SARS CoV2

We have been regularly tracking mutations of the virus throughout the pandemic to determine the impact it would have on our PCR sensitivity. To date, we have not seen any impact. Our current capacity for PCR tests is 270k and we continue to operate with a 1-2 day turnaround. The only way to identify the strain is by sequencing, and we have research support underway that includes sequencing of the virus.

Read more »
Jan 7 2021

Labcorp Awarded CDC Contract to Study Variants of COVID-19 Virus and Improve Public Health Response

Genomic Sequencing Aims to Help Define Changes in Transmission and Identify New Mutations

BURLINGTON, N.C.--(BUSINESS WIRE)--Jan. 7, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been awarded a contract from the Centers for Disease Control and Prevention (CDC) to provide genomic sequencing of samples of SARS-CoV-2, the virus that causes COVID-19.

Read more »
Dec 21 2020

Walgreens and Labcorp Make Pixel by Labcorp™ At-Home COVID-19 Collection Kit Available Through Walgreens Find Care®

Kit Can Allow More People to Get Tested, Helping Reduce the Spread of the Virus and Improving the Health of Communities

Read more »
Dec 9 2020

LabCorp Receives FDA Authorization to Make At-home COVID-19 Collection Kits Available Through Retail

Pixel by LabCorp™ COVID-19 Test Home Collection Kit is first to receive FDA authorization for over-the-counter purchase

Read more »
Dec 1 2020

Roche Receives FDA Emergency Use Authorization for New Semi-quantitative Test to Measure the Level of SARS-CoV-2 Antibodies

  • Elecsys® Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS-CoV-2 spike protein
  • The spike protein is the target of many COVID-19 vaccines in development
  • Semi-quantitative tests may help identify recovering patients who could potentially be serum and plasma donors for developing treatments for COVID-19
  • LabCorp is the first national laboratory to offer this test in the United States

INDIANAPOLIS, Dec.

Read more »
Oct 19 2020

LabCorp Launches Quantitative Antibody Test to Assess Effectiveness of COVID-19 Vaccines in Clinical Trials

Quantitative Test is Used to Assess Immune Response and to Support Other Scientific Research

Read more »
Oct 5 2020

CLEAR Adds LabCorp COVID-19 Test Results To “Health Pass” Mobile App

Eases the Ability to Safely Travel, Enter Workplaces, and Attend Public Events

Read more »

Labcorp's COVID-19 PCR Testing
Average Time to Result from Specimen Pickup

1-2 Days

Updated March 5, 2021

Testing Overview

37.5M

Molecular 
tests performed

275K

Molecular test 
capacity per day**

4.5M

Antibody
tests performed

300K

Antibody test 
capacity per day**

Tests Offered with No Upfront Costs*

Get COVID-19 Updates from Labcorp

Sign up to receive COVID-19 testing updates and other relevant messages from Labcorp.

Media Contacts

Email: ​[email protected]

Scroll back to top of page